NATERA, INC. Increase (Decrease) in Other Noncurrent Liabilities
NATERA, INC. (NTRA) reported Increase (Decrease) in Other Noncurrent Liabilities of -$1.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-07
- NATERA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$654.00K.
- NATERA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$920.00K.
- NATERA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $0.00.
- NATERA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-03-31 was $0.00.
- NATERA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $10.00K, a 96.77% decline from fiscal 2019.
- NATERA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2019 was $310.00K.
- NATERA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2017 was $1.33M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|
| 2026-06-30 | -$654.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$1.57M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | -$920.00K 10-Q · filed 2026-05-08 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | ||
| 2020-12-31 | $10.00K 10-K · filed 2023-03-01 | ||
| 2019-12-31 | $310.00K 10-K · filed 2022-02-25 | ||
| 2017-12-31 | $1.33M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |